NORRIS MEDICINES LTD. - Submission Of Standalone Unaudited Financial Results In Compliance With Regulation 33 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended 30.06.2021<BR>

Download	< Back
14 Aug 2021
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the following:<BR> 1) Standalone Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2021.<BR> <BR> 2) Limited Review Report on Standalone Unaudited Financial Results for the quarter ended on 30th June, 2021.<BR>
View all announcements for NORRIS MEDICINES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us